QR-kod

Immunogenicity, Safety and Efficacy of the Dengue Vaccine TAK-003: A Meta-Analysis

The TAK-003 dengue vaccine was licensed in Europe in December 2022, and the official recommendations from most EU countries are still under formulation. To support policymakers, we performed a meta-analysis to quantify TAK-003’s immunogenicity, efficacy and safety among seronegative and seropositive...

Full beskrivning

Sparad:
Huvudupphov: Maria Elena Flacco, Alessandro Bianconi, Giovanni Cioni, Matteo Fiore, Giovanna Letizia Calò, Gianmarco Imperiali, Vittorio Orazi, Marco Tiseo, Anastasia Troia, Annalisa Rosso, Lamberto Manzoli
Materialtyp: Artigo
Språk:Inglês
Utgiven: MDPI AG 2024-07-01
Serie:Vaccines
Ämnen:
dengue fever
dengue vaccine
TAK-003
immunogenicity
vaccine efficacy
vaccine safety
Länkar:https://www.mdpi.com/2076-393X/12/7/770
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk